Endpoints News 19. März 2026 Pfizer seeks earlier use of Talzenna in prostate cancer with Phase 3 win
Endpoints News 6. März 2026 Pfizer gets obesity drug approval in China shortly after buying local rights
Endpoints News 24. Feb. 2026 Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic push
Endpoints News 7. Feb. 2026 The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more
Endpoints News 3. Feb. 2026 Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings
Endpoints News 3. Feb. 2026 Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months
Endpoints News 8. Jan. 2026 French biotech Enodia gets €20.7M aided by Pfizer for protein degrader work
Endpoints News 5. Dez. 2025 OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
Endpoints News 4. Dez. 2025 Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen